Fosnight is the founder of the Fosnight Center for Sexual Health and a medical advisor for Aeroflow Urology.
Bladder symptoms during IVF carry systemic diagnostic cues, and integrating bladder health screening and pelvic floor referrals into routine IVF consultation—before symptoms develop—improves patient outcomes, according to Aleece Fosnight, MSPAS, PA-C.
Post-retrieval urinary symptoms often reflect physiologic changes rather than infection; urinalysis and culture should precede antibiotic prescribing, says Aleece Fosnight, MSPAS, PA-C.
Ob-gyn clinicians should counsel patients on microplastic exposure reduction through accessible, incremental steps rather than anxiety-inducing perfection, while resisting the clinical tendency to normalize bladder symptoms in younger women—with referral to urology or urogynecology warranted when symptoms persist, cultures are repeatedly negative, or hematuria or complex pelvic floor pain is present, according to Aleece Fosnight, MSPAS, PA-C.
Bladder symptoms in patients seeing ob-gyns require a multifactorial evaluation framework that builds patient timelines across medications, hormonal changes, pelvic floor function, and environmental exposures, whereas counseling on microplastic exposure during pregnancy should emphasize practical, evidence-based reduction strategies rather than fear, according to Aleece Fosnight, MSPAS, PA-C.
Clinicians evaluating women with new or worsening urinary incontinence should consider thyroid dysfunction—especially hypothyroidism—as a potential contributing factor, with overflow symptoms and systemic hypothyroid signs prompting laboratory evaluation and a comprehensive management approach.
According to Aleece Fosnight, MSPAS, PA-C, the physiologic effects of hypothyroidism can directly affect neuromuscular coordination, bladder emptying, and pelvic floor function.
